AKSHAYA BIO INC has a total of 12 patent applications. Its first patent ever was published in 2004. It filed its patents most often in Australia, EPO (European Patent Office) and United States. Its main competitors in its focus markets biotechnology and pharmaceuticals are TARGIMMUNE THERAPEUTICS AG, CODIAK BIOSCIENCES INC and NANJING KAEDI BIOTECH INC.
# | Country | Total Patents | |
---|---|---|---|
#1 | Australia | 5 | |
#2 | EPO (European Patent Office) | 2 | |
#3 | United States | 2 | |
#4 | Hong Kong | 1 | |
#5 | Japan | 1 | |
#6 | WIPO (World Intellectual Property Organization) | 1 |
# | Industry | |
---|---|---|
#1 | Biotechnology | |
#2 | Pharmaceuticals |
# | Technology | |
---|---|---|
#1 | Microorganisms | |
#2 | Medical preparations | |
#3 | Peptides | |
#4 | Therapeutic chemical compounds | |
#5 | Fermentation |
# | Name | Total Patents |
---|---|---|
#1 | Ma Allan | 10 |
#2 | George Rajan | 9 |
#3 | Noujaim Antoine | 9 |
#4 | Wang Dakun | 8 |
#5 | Tyrrell Lorne | 8 |
#6 | Rajan George | 3 |
#7 | Motyka Bruce | 2 |
#8 | Wang Dakan | 1 |
#9 | Noujaime Antoine | 1 |
#10 | Lorne Tyrrell | 1 |
Publication | Filing date | Title |
---|---|---|
WO2021007070A2 | Chimeric antigens for treating viral infection | |
AU2013204668A1 | Chimeric antigens for breaking host tolerance to foreign antigens | |
AU2013203598A1 | Chimeric antigen containing hepatitis c virus polypeptide and fc fragment for eliciting an immune response | |
AU2012200998A1 | Chimeric Antigens for Breaking Host Tolerance to Foreign Antigens |